Cathay Biotech Statistics
Total Valuation
Cathay Biotech has a market cap or net worth of CNY 30.07 billion. The enterprise value is 30.33 billion.
Market Cap | 30.07B |
Enterprise Value | 30.33B |
Important Dates
The last earnings date was Monday, October 28, 2024.
Earnings Date | Oct 28, 2024 |
Ex-Dividend Date | Jul 24, 2024 |
Share Statistics
Cathay Biotech has 581.32 million shares outstanding. The number of shares has increased by 0.97% in one year.
Current Share Class | n/a |
Shares Outstanding | 581.32M |
Shares Change (YoY) | +0.97% |
Shares Change (QoQ) | -2.82% |
Owned by Insiders (%) | 0.00% |
Owned by Institutions (%) | 16.32% |
Float | 216.18M |
Valuation Ratios
The trailing PE ratio is 76.02.
PE Ratio | 76.02 |
Forward PE | n/a |
PS Ratio | 10.94 |
PB Ratio | 2.62 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 50.39, with an EV/FCF ratio of -192.70.
EV / Earnings | 76.25 |
EV / Sales | 10.98 |
EV / EBITDA | 50.39 |
EV / EBIT | 98.12 |
EV / FCF | -192.70 |
Financial Position
The company has a current ratio of 2.87, with a Debt / Equity ratio of 0.09.
Current Ratio | 2.87 |
Quick Ratio | 2.16 |
Debt / Equity | 0.09 |
Debt / EBITDA | 2.13 |
Debt / FCF | -8.25 |
Interest Coverage | 10.09 |
Financial Efficiency
Return on equity (ROE) is 2.60% and return on invested capital (ROIC) is 1.19%.
Return on Equity (ROE) | 2.60% |
Return on Assets (ROA) | 1.06% |
Return on Capital (ROIC) | 1.19% |
Revenue Per Employee | 1.53M |
Profits Per Employee | 220,641 |
Employee Count | 1,803 |
Asset Turnover | 0.15 |
Inventory Turnover | 1.38 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +0.70% in the last 52 weeks. The beta is 0.64, so Cathay Biotech's price volatility has been lower than the market average.
Beta (5Y) | 0.64 |
52-Week Price Change | +0.70% |
50-Day Moving Average | 42.27 |
200-Day Moving Average | 43.96 |
Relative Strength Index (RSI) | 66.38 |
Average Volume (20 Days) | 5,148,759 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Cathay Biotech had revenue of CNY 2.76 billion and earned 397.82 million in profits. Earnings per share was 0.68.
Revenue | 2.76B |
Gross Profit | 846.65M |
Operating Income | 316.02M |
Pretax Income | 443.98M |
Net Income | 397.82M |
EBITDA | 608.83M |
EBIT | 316.02M |
Earnings Per Share (EPS) | 0.68 |
Balance Sheet
The company has 4.64 billion in cash and 1.30 billion in debt, giving a net cash position of 3.34 billion or 5.74 per share.
Cash & Cash Equivalents | 4.64B |
Total Debt | 1.30B |
Net Cash | 3.34B |
Net Cash Per Share | 5.74 |
Equity (Book Value) | 14.99B |
Book Value Per Share | 19.74 |
Working Capital | 4.44B |
Cash Flow
In the last 12 months, operating cash flow was 715.20 million and capital expenditures -872.61 million, giving a free cash flow of -157.41 million.
Operating Cash Flow | 715.20M |
Capital Expenditures | -872.61M |
Free Cash Flow | -157.41M |
FCF Per Share | -0.27 |
Margins
Gross margin is 30.63%, with operating and profit margins of 11.43% and 14.39%.
Gross Margin | 30.63% |
Operating Margin | 11.43% |
Pretax Margin | 16.06% |
Profit Margin | 14.39% |
EBITDA Margin | 22.03% |
EBIT Margin | 11.43% |
FCF Margin | -5.70% |
Dividends & Yields
This stock pays an annual dividend of 0.19, which amounts to a dividend yield of 0.37%.
Dividend Per Share | 0.19 |
Dividend Yield | 0.37% |
Dividend Growth (YoY) | 5.56% |
Years of Dividend Growth | n/a |
Payout Ratio | 35.32% |
Buyback Yield | -0.97% |
Shareholder Yield | -0.60% |
Earnings Yield | 1.32% |
FCF Yield | -0.52% |
Stock Splits
The last stock split was on July 20, 2022. It was a forward split with a ratio of 1.4.
Last Split Date | Jul 20, 2022 |
Split Type | Forward |
Split Ratio | 1.4 |
Scores
Cathay Biotech has an Altman Z-Score of 5.49.
Altman Z-Score | 5.49 |
Piotroski F-Score | n/a |